V029-1974 Screening compound: 5-(4-chlorobenzenesulfonamido)-1-[(3-methylphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

V029-1974 Screening compound: 5-(4-chlorobenzenesulfonamido)-1-[(3-methylphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide
V029-1974 Screening compound: 5-(4-chlorobenzenesulfonamido)-1-[(3-methylphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V029-1974
5-(4-chlorobenzenesulfonamido)-1-[(3-methylphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V029-1974

Molecular Formula

C30H27ClN4O3S (C30 H27 ClN4 O3 S)

Compound Name

5-(4-chlorobenzenesulfonamido)-1-[(3-methylphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

IUPAC name

5-(4-chlorobenzenesulfonamido)-1-[(3-methylphenyl)methyl]-N-[2-(pyridin-2-yl)ethyl]-1H-indole-2-carboxamide

SMILES

Cc1cccc(Cn(c(C(NCCc2ncccc2)=O)c2)c(cc3)c2cc3NS(c(cc2)ccc2Cl)(=O)=O)c1

InChI

InChI=1S/C30H27ClN4O3S/c1-21-5-4-6-22(17-21)20-35-28-13-10-26(34-39(37,38)27-11-8-24(31)9-12-27)18-23(28)19-29(35)30(36)33-16-14-25-7-2-3-15-32-25/h2-13,15,17-19,34H,14,16,20H2,1H3,(H,33,36)

InChI Key

MFBXUCBUOBQSJY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19779324

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

559.09

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

6.092

Distribution Coefficient, logD

6.081

Water Solubility, LogSw

-6.01

Polar Surface Area

75.140

Acid Dissociation Constant (pKa)

9.00

Base Dissociation Constant (pKb)

4.06

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.33

V029-1974 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Glucocorticoid receptors Library (4806 compounds)

Indole Derivatives (10091 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Nuclear receptors
  • Proteases
Mechanism of action:
  • Receptor's ligands
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with V029-1974 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V029-1974?
Check Price and Availability of V029-1974, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V029-1974 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V029-1974
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V029-1974
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V029-1974 available by request